ThZeal - The Zeal

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report: May 6, 2021

(Date of earliest event reported)

TENET HEALTHCARE CORPORATION

(Exact name of Registrant as specified in its charter)

Nevada

1-7293

95-2557091

(State of

Incorporation)

(Commission

File Number)

(IRS Employer

Identification Number)

14201 Dallas Parkway

Dallas, Texas 75254

(Address of principal executive offices, including zip code)

(469) 893-2200

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading symbol	Name of each exchange on which registered
Common stock $0.05 par value	THC	New York Stock Exchange
6.875% Senior Notes due 2031	THC31	New York Stock Exchange

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.07.

Submission of Matters to a Vote of Security Holders.

The 2021 Annual Meeting of Shareholders of Tenet Healthcare Corporation (the “Company”) was held on May 6, 2021. Below are the final voting results from the meeting.

1. The Company’s shareholders elected the following nominees to serve on the Company’s Board of Directors, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected or qualified, whichever is later, or until the director’s earlier resignation or removal:


	FOR		AGAINST		ABSTAIN		BROKER NON- VOTES		APPROVAL PERCENTAGE
Ronald A. Rittenmeyer		88,372,426		3,413,599		453,932		7,084,266		96.3	%
J. Robert Kerrey		87,284,073		4,914,574		532,178		7,084,266		94.7	%
James L. Bierman		91,444,053		754,561		41,343		7,084,266		99.2	%
Richard W. Fisher		91,061,517		1,136,170		42,270		7,084,266		98.8	%
Meghan M. FitzGerald		91,146,979		1,061,976		31,002		7,084,266		98.8	%
Cecil D. Haney		92,043,687		154,092		42,178		7,084,266		99.8	%
Christopher S. Lynch		91,061,359		1,136,148		42,450		7,084,266		98.8	%
Richard J. Mark		91,467,949		727,917		44,091		7,084,266		99.2	%
Tammy Romo		91,073,057		1,138,033		28,867		7,084,266		98.8	%
Saumya Sutaria		91,009,512		1,198,949		31,496		7,084,266		98.7	%
Nadja Y. West		91,877,958		331,696		30,303		7,084,266		99.6	%

2. The Company’s shareholders approved, on an advisory basis, the Company’s executive compensation:


FOR	AGAINST		ABSTAIN		BROKER NON- VOTES		APPROVAL PERCENTAGE
87,297,266		4,828,993		113,698		7,084,266		94.8	%

3. The Company’s shareholders approved the ratification of the selection of Deloitte & Touche LLP as the Company’s independent registered public accountants for the year ending December 31, 2021:


FOR	AGAINST		ABSTAIN		BROKER NON- VOTES		APPROVAL PERCENTAGE
98,201,144		1,073,130		49,949		—		98.9	%


	TENET HEALTHCARE CORPORATION

Date: May 12, 2021	By:	/s/ Thomas Arnst
	Name:	Thomas Arnst
	Title:	Executive Vice President, Chief Administrative
		Officer and General Counsel